ACET - アセト (Aceto Corporation) アセト

 ACETのチャート


 ACETの企業情報

symbol ACET
会社名 Aceto Corp (アセト)
分野(sector) Health Care   ヘルスケア
産業(industry) Other Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 アセト(Aceto Corporation)は完成剤形のジェネリック医薬品、栄養補助食品、医薬活性成分、農業中間体と農産物保護製品等の特殊化学製品のマーケティング・販売を行う。同社はヒューマンヘルス、医薬品原料と機能化学品という3つの事業セグメントを運営する。ヒューマンヘルス事業には、ジェネリック医薬品と栄養補助食品を含む。機能化学品事業は特殊化学品、農業保護製品を含む。   アセトは米国の医薬品原料・化学品販売会社。プラスチック原料、プラスチック用酸化防止剤、界面活性剤、潤滑油などの工業薬品のほか、医薬品、生化学品、栄養剤、医薬品中間物、農薬、有機中間物、色素などを販売する。本社はニューヨーク州ポ―トワシントン。   Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
本社所在地 4 Tri Harbor Court Port Washington NY 11050 USA
代表者氏名 William C. Kennally ウィリアム・C.・ケンナリー
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 516-627-6000
設立年月日 17319
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 315人
url www.aceto.com
nasdaq_url https://www.nasdaq.com/symbol/acet
adr_tso
EBITDA EBITDA(百万ドル) 14.06600
終値(lastsale) 2.37
時価総額(marketcap) 72965761.17
時価総額 時価総額(百万ドル) 68.65555
売上高 売上高(百万ドル) 711.35900
企業価値(EV) 企業価値(EV)(百万ドル) 282.14955
当期純利益 当期純利益(百万ドル) -304.82700
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Aceto Corporation revenues increased 11% to $711.4M. Net loss before extraordinary items totaled $304.8M vs. income of $11.4M. Revenues reflect Human health segment increase of 19% to $374.5M Performance Chemicals segment increase of 8% to $178M United States segment increase of 11% to $535.7M Germany segment increase of 22% to $96.7M. Net loss reflects Selling.

 ACETのテクニカル分析


 ACETのニュース

   Future Outlook And Stock Price Performance For Adicet Bio Inc. (NASDAQ: ACET)  2022/06/01 11:00:00 Marketing Sentinel
In the last trading session, 1.1 million shares of the Adicet Bio Inc. (NASDAQ:ACET) were traded, and its beta was 2.65. Most recently the company’s share price was $11.82, and it changed around $0.07 or 0.60% from the last close, which brings the market valuation of the company to $412.87M. ACET currently trades at a … Future Outlook And Stock Price Performance For Adicet Bio Inc. (NASDAQ: ACET) Read More »
   FMC Files Patent Lawsuit Against Aceto US  2022/05/04 20:32:44 Wallstreet:Online
(PLX AI) – FMC Corporation files patent infringement lawsuit in the U.S. against Aceto US, LLC.The complaint, filed in the United States District Court for the District of Delaware, alleges Aceto is infringing on FMC patents relating to …
   Erythromycin Market Rising Trends, Latest Technologies Research and Future Scope 2021-2028 | Ani Pharmaceuticals, Akorn, Inc., Aceto Corporation, Genesis Pharmaceuticals  2021/10/22 07:04:23 OpenPR
Erythromycin Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the
   Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer  2021/10/12 11:30:00 Business Wire
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- #ACBioBuffer--A&C Bio Buffers custom buffer and chemical blend portfolio complements Acetos manufacturing footprint and strengthens its presence in Europe.
   Pharmaceutical Intermediates Market 2021 Competitive Analysis- Aceto Corporation, BASF SE, Chiracon GmbH, Dishman Group  2021/07/20 13:17:35 OpenPR
The report presents an in-depth assessment of the Pharmaceutical Intermediates Market including enabling technologies, key trends, market drivers, challenges, regulatory landscape, deployment models, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Pharmaceutical
   FMC Files Patent Lawsuit Against Aceto US  2022/05/04 20:32:44 Wallstreet:Online
(PLX AI) – FMC Corporation files patent infringement lawsuit in the U.S. against Aceto US, LLC.The complaint, filed in the United States District Court for the District of Delaware, alleges Aceto is infringing on FMC patents relating to …
   Erythromycin Market Rising Trends, Latest Technologies Research and Future Scope 2021-2028 | Ani Pharmaceuticals, Akorn, Inc., Aceto Corporation, Genesis Pharmaceuticals  2021/10/22 07:04:23 OpenPR
Erythromycin Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the
   Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer  2021/10/12 11:30:00 Business Wire
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- #ACBioBuffer--A&C Bio Buffers custom buffer and chemical blend portfolio complements Acetos manufacturing footprint and strengthens its presence in Europe.
   Pharmaceutical Intermediates Market 2021 Competitive Analysis- Aceto Corporation, BASF SE, Chiracon GmbH, Dishman Group  2021/07/20 13:17:35 OpenPR
The report presents an in-depth assessment of the Pharmaceutical Intermediates Market including enabling technologies, key trends, market drivers, challenges, regulatory landscape, deployment models, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Pharmaceutical
   Ontario Securities Commission; Former Officers And Directors Of CannTrust Charged With Securities Act Offences  2021/06/22 20:02:21 MondoVisione
Following a joint investigation by the OSC and Royal Canadian Mounted Police (RCMP), Integrated Market Enforcement Team (IMET), three former directors and officers at CannTrust Holdings Inc. (CannTrust) have been charged with offences under the Securities Act (Ontario). Charges include: Mark Litwin from Toronto, Ontario: Fraud Insider trading Making a false prospectus and false preliminary prospectus Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence Eric Paul from Toronto, Ontario: Fraud Insider trading Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence. Peter Aceto from Toronto, Ontario: Fraud Making false or misleading statements to the OSC and to the market Making a false prospectus and false preliminary prospectus Authorizing, permitting or acquiescing in the commission of an offence These allegations relate to efforts to conceal the illegal growing of cannabis at CannTrust over a 10-month period in 2018 and 2019.
   Erythromycin Market Rising Trends, Latest Technologies Research and Future Scope 2021-2028 | Ani Pharmaceuticals, Akorn, Inc., Aceto Corporation, Genesis Pharmaceuticals  2021/10/22 07:04:23 OpenPR
Erythromycin Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the
   Aceto Expands GMP Product Lines for Biopharmaceutical and Vaccine Manufacturing with Acquisition of A&C Bio Buffer  2021/10/12 11:30:00 Business Wire
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- #ACBioBuffer--A&C Bio Buffers custom buffer and chemical blend portfolio complements Acetos manufacturing footprint and strengthens its presence in Europe.
   Pharmaceutical Intermediates Market 2021 Competitive Analysis- Aceto Corporation, BASF SE, Chiracon GmbH, Dishman Group  2021/07/20 13:17:35 OpenPR
The report presents an in-depth assessment of the Pharmaceutical Intermediates Market including enabling technologies, key trends, market drivers, challenges, regulatory landscape, deployment models, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Pharmaceutical
   Ontario Securities Commission; Former Officers And Directors Of CannTrust Charged With Securities Act Offences  2021/06/22 20:02:21 MondoVisione
Following a joint investigation by the OSC and Royal Canadian Mounted Police (RCMP), Integrated Market Enforcement Team (IMET), three former directors and officers at CannTrust Holdings Inc. (CannTrust) have been charged with offences under the Securities Act (Ontario). Charges include: Mark Litwin from Toronto, Ontario: Fraud Insider trading Making a false prospectus and false preliminary prospectus Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence Eric Paul from Toronto, Ontario: Fraud Insider trading Making false or misleading statements to the OSC and to the market Authorizing, permitting or acquiescing in the commission of an offence. Peter Aceto from Toronto, Ontario: Fraud Making false or misleading statements to the OSC and to the market Making a false prospectus and false preliminary prospectus Authorizing, permitting or acquiescing in the commission of an offence These allegations relate to efforts to conceal the illegal growing of cannabis at CannTrust over a 10-month period in 2018 and 2019.
   Aceto Propels Growth Strategy with Cascade Chemistry Acquisition  2021/06/02 00:00:00 BioSpace
Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced the acquisition of Eugene, Oregon-based Cascade Chemistry, manufacturer of active pharmaceutical ingredients, regulatory starting materials and advanced intermediates.

 関連キーワード  (医薬品 米国株 アセト ACET Aceto Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)